Sitagliptin 2-Desfluoro Impurity:
(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(4,5-difluorophenyl)butan-2-amine ; C16H16F5N5O ; MW: 389.32 ; |
Sitagliptin Desfluorobenzene Analog :
(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-phenylbutan-2-amine ; C16H18F3N5O ; Mol. Wt.: 353.34 ; |
Sitagliptin Enamine Impurity :
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine ; CAS : 767340-03-4 ; C16H13F6N5O ; MW: 405.30 ; |
Sitagliptin Impurity A :
Sitagliptin (S)-Isomer Phosphate Salt ; CAS : 823817-58-9 ; C16H18F6N5O5P ; MW: 505.31 ; |
Sitagliptin Impurity B :
4-Desfluoro Sitagliptin ; CAS : 1345822-87-8 ; C16H16F5N5O ; MW: 389.32 ; |
Sitagliptin Impurity C:
5-Desfluoro Sitagliptin ; CAS : 1345822-86-7 ; C16H16F5N5O ; MW: 389.32 ; |
Sitagliptin Hydroxy Amide Impurity:
3-Hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one ; C16H14F6N4O2 ; MW: 408.3 ; |
Sitagliptin Ketoamide Impurity :
(2Z)-4-Oxo-4-[3-(trifluoroMethyl)-5,6-dihydro-[1,2,4] triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one ; CAS : 764667-65-4 ; C16H12F6N4O2 ; MW: 406.28 ; |
Sitagliptin N-Acetyl Impurity:
7-[(3R)-3-[(N-Acetyl)amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine ; CAS : 1379666-94-0 ; C18H17F6N5O2 ; MW: 449.35 ; |
Sitagliptin Phosphate Hydrate:
(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate hydrate ; CAS : 654671-77-9 ; C16H15F6N5O (base) ; MW: 407.31 ; C16H20F6N5O6P (phosphate hydrate) ; MW: 523.32 ; |
Sitagliptin Triazole Hydrochloride:
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride ; CAS : 762240-92-6 ; C6H8ClF3N4 ;MW: 228.60 ; |
Sitagliptin FP Impurity A:
N-[(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]aspartic acid ; C20H19F6N5O5 ; MW: 523.39 ; |
Sitagliptin FP Impurity B :
10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro [1,2,4] triazolo [3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione ; C16H13F6N5O2 ; MW: 421.3 ; |
Sitagliptin FP Impurity C :
(3E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-3-en-1-one ; C16H12F6N4O ; MW: 390.28 ; |
Sitagliptin FP Impurity D:
3-Desamino-2,3-Dehydro Sitagliptin ; CAS : 1253056-18-6 ; C16H12F6N4O ; MW: 390.28 ; |
Sitagliptin FP Impurity E:
(3R-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid ; CAS : 936630-57-8 ; C10H10F3NO2 ; MW: 233.19 ; |